Amdocs Limited (NASDAQ:DOX) Shares Sold by Dudley & Shanley Inc.

Dudley & Shanley Inc. reduced its stake in Amdocs Limited (NASDAQ:DOX) by 13.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 225,381 shares of the technology company’s stock after selling 36,445 shares during the period. Amdocs makes up about 3.0% of Dudley & Shanley Inc.’s holdings, making the stock its 17th largest holding. Dudley & Shanley Inc. owned about 0.20% of Amdocs worth $19,189,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First Horizon Advisors Inc. increased its holdings in Amdocs by 1.9% in the third quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company’s stock valued at $516,000 after buying an additional 109 shares during the last quarter. Private Trust Co. NA raised its position in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after acquiring an additional 117 shares in the last quarter. Natixis Advisors LLC lifted its stake in Amdocs by 0.4% during the second quarter. Natixis Advisors LLC now owns 27,246 shares of the technology company’s stock worth $2,150,000 after purchasing an additional 120 shares during the last quarter. Morton Community Bank boosted its holdings in Amdocs by 0.4% in the third quarter. Morton Community Bank now owns 36,410 shares of the technology company’s stock valued at $3,185,000 after purchasing an additional 130 shares in the last quarter. Finally, Y.D. More Investments Ltd increased its stake in Amdocs by 1.5% in the second quarter. Y.D. More Investments Ltd now owns 9,389 shares of the technology company’s stock valued at $741,000 after purchasing an additional 139 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

Amdocs Price Performance

Shares of Amdocs stock traded down $0.09 during trading on Friday, reaching $84.07. The company’s stock had a trading volume of 189,548 shares, compared to its average volume of 358,495. The business has a 50 day moving average price of $87.20 and a 200-day moving average price of $85.34. The company has a market capitalization of $9.49 billion, a P/E ratio of 19.83, a price-to-earnings-growth ratio of 1.45 and a beta of 0.72. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.479 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Tuesday, December 31st. Amdocs’s dividend payout ratio (DPR) is 45.05%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Oppenheimer raised their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Stifel Nicolaus started coverage on Amdocs in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price objective for the company. Barclays cut their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. Finally, StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 14th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.